Action of orciprenaline on uterine contractility during labor, maternal cardiovascular system, fetal heart rate, and acid-base balance.
D001794:Blood Pressure / Q000187:drug effects; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D002319:Cardiovascular System / Q000187:drug effects*; D005260:Female; D005318:Fetal Heart / Q000187:drug effects*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007743:Labor, Obstetric; D009921:Metaproterenol / Q000008:administration & dosage / Q000009:adverse effects; D009119:Muscle Contraction / Q000187:drug effects; D010627:Phenethylamines / Q000627:therapeutic use*; D011247:Pregnancy; D012118:Resorcinols / Q000627:therapeutic use*; D013610:Tachycardia / Q000139:chemically induced; D013997:Time Factors; D014599:Uterus / Q000187:drug effects*
D001993:Bronchodilator Agents; D010627:Phenethylamines; D012118:Resorcinols; D009921:Metaproterenol